Pharma & Healthcare
Global Human Coagulation Factor VIII Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 168344
- Pages: 105
- Figures: 105
- Views: 45
The global Human Coagulation Factor VIII market size was US$ 11550 million in 2024 and is forecast to a readjusted size of US$ 17610 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
The global Human Coagulation Factor VIII market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
SinoCellTech
Taibang Bio
Huarun Boya
Shuanglin Bio
Yuandashuyang
Weiguang Bio
By Type: (Dominant Segment vs High-Margin Innovation)
Recombinant Factor VIII
Plasma-derived Factor VIII
By Application: (Core Demand Driver vs Emerging Opportunity)
Hemophilia A
Spontanous / Trauma
Surgical
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Takeda in Europe)
- Emerging Product Trends: Recombinant Factor VIII adoption vs. Plasma-derived Factor VIII premiumization
- Demand-Side Dynamics: Hemophilia A growth in China vs. Spontanous / Trauma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Coagulation Factor VIII market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Plasma-derived Factor VIII in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Spontanous / Trauma in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Recombinant Factor VIII dominance in Europe vs. Plasma-derived Factor VIII demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
Market Drivers:
The increasing prevalence of hemophilia A is a key driver for the Human Coagulation Factor VIII market. As awareness and diagnosis rates improve, more patients are receiving proper treatment, driving demand for Factor VIII therapies. Additionally, advancements in biotechnology, including the development of recombinant and extended half-life Factor VIII products, have significantly improved treatment efficacy and patient convenience. Government initiatives and healthcare programs supporting rare disease treatments, along with expanded access to hemophilia care in developing regions, further boost market growth. The rise of gene therapy research also presents potential future opportunities for transforming the hemophilia treatment landscape.
Market Challenges:
Despite strong market growth, several challenges persist, including the high cost of Factor VIII therapies, which limits affordability and accessibility for many patients, especially in low-income regions. Additionally, plasma-derived Factor VIII products face supply chain constraints due to reliance on blood donations. Another major challenge is the development of inhibitors (antibodies) in some patients, which can render Factor VIII treatment ineffective and necessitate alternative therapies. Regulatory complexities and the need for stringent quality control in manufacturing also pose barriers for new entrants in the market.
The global Human Coagulation Factor VIII market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
SinoCellTech
Taibang Bio
Huarun Boya
Shuanglin Bio
Yuandashuyang
Weiguang Bio
By Type: (Dominant Segment vs High-Margin Innovation)
Recombinant Factor VIII
Plasma-derived Factor VIII
By Application: (Core Demand Driver vs Emerging Opportunity)
Hemophilia A
Spontanous / Trauma
Surgical
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Takeda in Europe)
- Emerging Product Trends: Recombinant Factor VIII adoption vs. Plasma-derived Factor VIII premiumization
- Demand-Side Dynamics: Hemophilia A growth in China vs. Spontanous / Trauma potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Coagulation Factor VIII market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Plasma-derived Factor VIII in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Spontanous / Trauma in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Recombinant Factor VIII dominance in Europe vs. Plasma-derived Factor VIII demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2020 & 2024 & 2031)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Coagulation Factor VIII Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Coagulation Factor VIII Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.2 Europe Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.3 China Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.4 Korea Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2020-2025)
3.1.1 Global Human Coagulation Factor VIII Sales by Type (2020-2025)
3.1.2 Global Human Coagulation Factor VIII Revenue by Type (2020-2025)
3.1.3 Global Human Coagulation Factor VIII Price by Type (2020-2025)
3.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2026-2031)
3.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2026-2031)
3.3 Different Types Human Coagulation Factor VIII Representative Players
4 Global Market Size by Application
4.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Sales by Application (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Revenue by Application (2020-2025)
4.1.3 Global Human Coagulation Factor VIII Price by Application (2020-2025)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2026-2031)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Coagulation Factor VIII Application
5 Competition Landscape by Players
5.1 Global Human Coagulation Factor VIII Sales by Players (2020-2025)
5.2 Global Top Human Coagulation Factor VIII Players by Revenue (2020-2025)
5.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
5.4 Global Human Coagulation Factor VIII Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
5.7 Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Coagulation Factor VIII Sales by Company
6.1.1.1 North America Human Coagulation Factor VIII Sales by Company (2020-2025)
6.1.1.2 North America Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.1.2 North America Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Coagulation Factor VIII Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Coagulation Factor VIII Sales by Company
6.2.1.1 Europe Human Coagulation Factor VIII Sales by Company (2020-2025)
6.2.1.2 Europe Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.2.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Coagulation Factor VIII Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Coagulation Factor VIII Sales by Company
6.3.1.1 China Human Coagulation Factor VIII Sales by Company (2020-2025)
6.3.1.2 China Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.3.2 China Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.3.3 China Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.3.4 China Human Coagulation Factor VIII Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Korea Market: Players, Segments, Downstream and Major Customers
6.4.1 Korea Human Coagulation Factor VIII Sales by Company
6.4.1.1 Korea Human Coagulation Factor VIII Sales by Company (2020-2025)
6.4.1.2 Korea Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.4.2 Korea Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.4.3 Korea Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.4.4 Korea Human Coagulation Factor VIII Major Customer
6.4.5 Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Takeda Human Coagulation Factor VIII Products Offered
7.1.5 Takeda Recent Development
7.2 Bayer
7.2.1 Bayer Company Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bayer Human Coagulation Factor VIII Products Offered
7.2.5 Bayer Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Business Overview
7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CSL Human Coagulation Factor VIII Products Offered
7.3.5 CSL Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Pfizer Human Coagulation Factor VIII Products Offered
7.4.5 Pfizer Recent Development
7.5 Grifols
7.5.1 Grifols Company Information
7.5.2 Grifols Business Overview
7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Grifols Human Coagulation Factor VIII Products Offered
7.5.5 Grifols Recent Development
7.6 Biogen
7.6.1 Biogen Company Information
7.6.2 Biogen Business Overview
7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Biogen Human Coagulation Factor VIII Products Offered
7.6.5 Biogen Recent Development
7.7 Octapharma
7.7.1 Octapharma Company Information
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Octapharma Human Coagulation Factor VIII Products Offered
7.7.5 Octapharma Recent Development
7.8 NovoNordisk
7.8.1 NovoNordisk Company Information
7.8.2 NovoNordisk Business Overview
7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
7.8.5 NovoNordisk Recent Development
7.9 Greencross
7.9.1 Greencross Company Information
7.9.2 Greencross Business Overview
7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Greencross Human Coagulation Factor VIII Products Offered
7.9.5 Greencross Recent Development
7.10 Kedrion
7.10.1 Kedrion Company Information
7.10.2 Kedrion Business Overview
7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Kedrion Human Coagulation Factor VIII Products Offered
7.10.5 Kedrion Recent Development
7.11 BPL
7.11.1 BPL Company Information
7.11.2 BPL Business Overview
7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.11.4 BPL Human Coagulation Factor VIII Products Offered
7.11.5 BPL Recent Development
7.12 Hualan Bio
7.12.1 Hualan Bio Company Information
7.12.2 Hualan Bio Business Overview
7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
7.12.5 Hualan Bio Recent Development
7.13 RAAS
7.13.1 RAAS Company Information
7.13.2 RAAS Business Overview
7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.13.4 RAAS Human Coagulation Factor VIII Products Offered
7.13.5 RAAS Recent Development
7.14 SinoCellTech
7.14.1 SinoCellTech Company Information
7.14.2 SinoCellTech Business Overview
7.14.3 SinoCellTech Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.14.4 SinoCellTech Human Coagulation Factor VIII Products Offered
7.14.5 SinoCellTech Recent Development
7.15 Taibang Bio
7.15.1 Taibang Bio Company Information
7.15.2 Taibang Bio Business Overview
7.15.3 Taibang Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Taibang Bio Human Coagulation Factor VIII Products Offered
7.15.5 Taibang Bio Recent Development
7.16 Huarun Boya
7.16.1 Huarun Boya Company Information
7.16.2 Huarun Boya Business Overview
7.16.3 Huarun Boya Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Huarun Boya Human Coagulation Factor VIII Products Offered
7.16.5 Huarun Boya Recent Development
7.17 Shuanglin Bio
7.17.1 Shuanglin Bio Company Information
7.17.2 Shuanglin Bio Business Overview
7.17.3 Shuanglin Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Shuanglin Bio Human Coagulation Factor VIII Products Offered
7.17.5 Shuanglin Bio Recent Development
7.18 Yuandashuyang
7.18.1 Yuandashuyang Company Information
7.18.2 Yuandashuyang Business Overview
7.18.3 Yuandashuyang Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Yuandashuyang Human Coagulation Factor VIII Products Offered
7.18.5 Yuandashuyang Recent Development
7.19 Weiguang Bio
7.19.1 Weiguang Bio Company Information
7.19.2 Weiguang Bio Business Overview
7.19.3 Weiguang Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Weiguang Bio Human Coagulation Factor VIII Products Offered
7.19.5 Weiguang Bio Recent Development
8 Human Coagulation Factor VIII Manufacturing Cost Analysis
8.1 Human Coagulation Factor VIII Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
8.4 Human Coagulation Factor VIII Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Coagulation Factor VIII Distributors List
9.3 Human Coagulation Factor VIII Customers
10 Human Coagulation Factor VIII Market Dynamics
10.1 Human Coagulation Factor VIII Industry Trends
10.2 Human Coagulation Factor VIII Market Drivers
10.3 Human Coagulation Factor VIII Market Challenges
10.4 Human Coagulation Factor VIII Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2020 & 2024 & 2031)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Global Human Coagulation Factor VIII Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Coagulation Factor VIII Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Coagulation Factor VIII Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.2 Europe Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.3 China Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
2.4.4 Korea Human Coagulation Factor VIII Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2020-2025)
3.1.1 Global Human Coagulation Factor VIII Sales by Type (2020-2025)
3.1.2 Global Human Coagulation Factor VIII Revenue by Type (2020-2025)
3.1.3 Global Human Coagulation Factor VIII Price by Type (2020-2025)
3.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2026-2031)
3.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2026-2031)
3.3 Different Types Human Coagulation Factor VIII Representative Players
4 Global Market Size by Application
4.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Sales by Application (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Revenue by Application (2020-2025)
4.1.3 Global Human Coagulation Factor VIII Price by Application (2020-2025)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2026-2031)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Coagulation Factor VIII Application
5 Competition Landscape by Players
5.1 Global Human Coagulation Factor VIII Sales by Players (2020-2025)
5.2 Global Top Human Coagulation Factor VIII Players by Revenue (2020-2025)
5.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
5.4 Global Human Coagulation Factor VIII Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
5.7 Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Coagulation Factor VIII Sales by Company
6.1.1.1 North America Human Coagulation Factor VIII Sales by Company (2020-2025)
6.1.1.2 North America Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.1.2 North America Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Coagulation Factor VIII Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Coagulation Factor VIII Sales by Company
6.2.1.1 Europe Human Coagulation Factor VIII Sales by Company (2020-2025)
6.2.1.2 Europe Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.2.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Coagulation Factor VIII Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Coagulation Factor VIII Sales by Company
6.3.1.1 China Human Coagulation Factor VIII Sales by Company (2020-2025)
6.3.1.2 China Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.3.2 China Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.3.3 China Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.3.4 China Human Coagulation Factor VIII Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Korea Market: Players, Segments, Downstream and Major Customers
6.4.1 Korea Human Coagulation Factor VIII Sales by Company
6.4.1.1 Korea Human Coagulation Factor VIII Sales by Company (2020-2025)
6.4.1.2 Korea Human Coagulation Factor VIII Revenue by Company (2020-2025)
6.4.2 Korea Human Coagulation Factor VIII Sales Breakdown by Type (2020-2025)
6.4.3 Korea Human Coagulation Factor VIII Sales Breakdown by Application (2020-2025)
6.4.4 Korea Human Coagulation Factor VIII Major Customer
6.4.5 Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Takeda Human Coagulation Factor VIII Products Offered
7.1.5 Takeda Recent Development
7.2 Bayer
7.2.1 Bayer Company Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bayer Human Coagulation Factor VIII Products Offered
7.2.5 Bayer Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Business Overview
7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CSL Human Coagulation Factor VIII Products Offered
7.3.5 CSL Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Pfizer Human Coagulation Factor VIII Products Offered
7.4.5 Pfizer Recent Development
7.5 Grifols
7.5.1 Grifols Company Information
7.5.2 Grifols Business Overview
7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Grifols Human Coagulation Factor VIII Products Offered
7.5.5 Grifols Recent Development
7.6 Biogen
7.6.1 Biogen Company Information
7.6.2 Biogen Business Overview
7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Biogen Human Coagulation Factor VIII Products Offered
7.6.5 Biogen Recent Development
7.7 Octapharma
7.7.1 Octapharma Company Information
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Octapharma Human Coagulation Factor VIII Products Offered
7.7.5 Octapharma Recent Development
7.8 NovoNordisk
7.8.1 NovoNordisk Company Information
7.8.2 NovoNordisk Business Overview
7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
7.8.5 NovoNordisk Recent Development
7.9 Greencross
7.9.1 Greencross Company Information
7.9.2 Greencross Business Overview
7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Greencross Human Coagulation Factor VIII Products Offered
7.9.5 Greencross Recent Development
7.10 Kedrion
7.10.1 Kedrion Company Information
7.10.2 Kedrion Business Overview
7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Kedrion Human Coagulation Factor VIII Products Offered
7.10.5 Kedrion Recent Development
7.11 BPL
7.11.1 BPL Company Information
7.11.2 BPL Business Overview
7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.11.4 BPL Human Coagulation Factor VIII Products Offered
7.11.5 BPL Recent Development
7.12 Hualan Bio
7.12.1 Hualan Bio Company Information
7.12.2 Hualan Bio Business Overview
7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
7.12.5 Hualan Bio Recent Development
7.13 RAAS
7.13.1 RAAS Company Information
7.13.2 RAAS Business Overview
7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.13.4 RAAS Human Coagulation Factor VIII Products Offered
7.13.5 RAAS Recent Development
7.14 SinoCellTech
7.14.1 SinoCellTech Company Information
7.14.2 SinoCellTech Business Overview
7.14.3 SinoCellTech Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.14.4 SinoCellTech Human Coagulation Factor VIII Products Offered
7.14.5 SinoCellTech Recent Development
7.15 Taibang Bio
7.15.1 Taibang Bio Company Information
7.15.2 Taibang Bio Business Overview
7.15.3 Taibang Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Taibang Bio Human Coagulation Factor VIII Products Offered
7.15.5 Taibang Bio Recent Development
7.16 Huarun Boya
7.16.1 Huarun Boya Company Information
7.16.2 Huarun Boya Business Overview
7.16.3 Huarun Boya Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Huarun Boya Human Coagulation Factor VIII Products Offered
7.16.5 Huarun Boya Recent Development
7.17 Shuanglin Bio
7.17.1 Shuanglin Bio Company Information
7.17.2 Shuanglin Bio Business Overview
7.17.3 Shuanglin Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Shuanglin Bio Human Coagulation Factor VIII Products Offered
7.17.5 Shuanglin Bio Recent Development
7.18 Yuandashuyang
7.18.1 Yuandashuyang Company Information
7.18.2 Yuandashuyang Business Overview
7.18.3 Yuandashuyang Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Yuandashuyang Human Coagulation Factor VIII Products Offered
7.18.5 Yuandashuyang Recent Development
7.19 Weiguang Bio
7.19.1 Weiguang Bio Company Information
7.19.2 Weiguang Bio Business Overview
7.19.3 Weiguang Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Weiguang Bio Human Coagulation Factor VIII Products Offered
7.19.5 Weiguang Bio Recent Development
8 Human Coagulation Factor VIII Manufacturing Cost Analysis
8.1 Human Coagulation Factor VIII Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
8.4 Human Coagulation Factor VIII Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Coagulation Factor VIII Distributors List
9.3 Human Coagulation Factor VIII Customers
10 Human Coagulation Factor VIII Market Dynamics
10.1 Human Coagulation Factor VIII Industry Trends
10.2 Human Coagulation Factor VIII Market Drivers
10.3 Human Coagulation Factor VIII Market Challenges
10.4 Human Coagulation Factor VIII Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VIII Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Human Coagulation Factor VIII Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Human Coagulation Factor VIII Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Coagulation Factor VIII Sales (K Bottles) by Region (2020-2025)
Table 5. Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Human Coagulation Factor VIII Revenue Share by Region (2020-2025)
Table 8. Global Human Coagulation Factor VIII Sales (K Bottles) Forecast by Region (2026-2031)
Table 9. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Human Coagulation Factor VIII Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Human Coagulation Factor VIII Revenue Share Forecast by Region (2026-2031)
Table 12. Global Human Coagulation Factor VIII Sales by Type (K Bottles) & (2020-2025)
Table 13. Global Human Coagulation Factor VIII Sales Share by Type (2020-2025)
Table 14. Global Human Coagulation Factor VIII Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Human Coagulation Factor VIII Price by Type (USD/Bottle) & (2020-2025)
Table 16. Global Human Coagulation Factor VIII Sales by Type (K Bottles) & (2026-2031)
Table 17. Global Human Coagulation Factor VIII Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Human Coagulation Factor VIII Price by Type (USD/Bottle) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Human Coagulation Factor VIII Sales by Application (K Bottles) & (2020-2025)
Table 21. Global Human Coagulation Factor VIII Sales Share by Application (2020-2025)
Table 22. Global Human Coagulation Factor VIII Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Human Coagulation Factor VIII Price by Application (USD/Bottle) & (2020-2025)
Table 24. Global Human Coagulation Factor VIII Sales by Application (K Bottles) & (2026-2031)
Table 25. Global Human Coagulation Factor VIII Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Human Coagulation Factor VIII Price by Application (USD/Bottle) & (2026-2031)
Table 27. New Sources of Growth in Human Coagulation Factor VIII Application
Table 28. Global Human Coagulation Factor VIII Sales by Company (K Bottles) & (2020-2025)
Table 29. Global Human Coagulation Factor VIII Sales Share by Company (2020-2025)
Table 30. Global Human Coagulation Factor VIII Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Human Coagulation Factor VIII Revenue Share by Company (2020-2025)
Table 32. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
Table 33. Global Market Human Coagulation Factor VIII Average Price by Company (USD/Bottle) & (2020-2025)
Table 34. Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
Table 36. Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 39. North America Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 40. North America Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 42. North America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 43. North America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 44. North America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 45. North America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 46. Europe Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 47. Europe Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 48. Europe Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 50. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 52. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 53. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 54. China Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 55. China Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 56. China Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 58. China Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 59. China Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 60. China Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 61. China Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 62. Korea Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 63. Korea Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 64. Korea Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 65. Korea Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 66. Korea Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 67. Korea Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 68. Korea Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 69. Korea Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 73. Takeda Human Coagulation Factor VIII Product
Table 74. Takeda Recent Development
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 78. Bayer Human Coagulation Factor VIII Product
Table 79. Bayer Recent Development
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 83. CSL Human Coagulation Factor VIII Product
Table 84. CSL Recent Development
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. Pfizer Human Coagulation Factor VIII Product
Table 89. Pfizer Recent Development
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 93. Grifols Human Coagulation Factor VIII Product
Table 94. Grifols Recent Development
Table 95. Biogen Company Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 98. Biogen Human Coagulation Factor VIII Product
Table 99. Biogen Recent Development
Table 100. Octapharma Company Information
Table 101. Octapharma Description and Business Overview
Table 102. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 103. Octapharma Human Coagulation Factor VIII Product
Table 104. Octapharma Recent Development
Table 105. NovoNordisk Company Information
Table 106. NovoNordisk Description and Business Overview
Table 107. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 108. NovoNordisk Human Coagulation Factor VIII Product
Table 109. NovoNordisk Recent Development
Table 110. Greencross Company Information
Table 111. Greencross Description and Business Overview
Table 112. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 113. Greencross Human Coagulation Factor VIII Product
Table 114. Greencross Recent Development
Table 115. Kedrion Company Information
Table 116. Kedrion Description and Business Overview
Table 117. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 118. Kedrion Human Coagulation Factor VIII Product
Table 119. Kedrion Recent Development
Table 120. BPL Company Information
Table 121. BPL Description and Business Overview
Table 122. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 123. BPL Human Coagulation Factor VIII Product
Table 124. BPL Recent Development
Table 125. Hualan Bio Company Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. Hualan Bio Human Coagulation Factor VIII Product
Table 129. Hualan Bio Recent Development
Table 130. RAAS Company Information
Table 131. RAAS Description and Business Overview
Table 132. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 133. RAAS Human Coagulation Factor VIII Product
Table 134. RAAS Recent Development
Table 135. SinoCellTech Company Information
Table 136. SinoCellTech Description and Business Overview
Table 137. SinoCellTech Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 138. SinoCellTech Human Coagulation Factor VIII Product
Table 139. SinoCellTech Recent Development
Table 140. Taibang Bio Company Information
Table 141. Taibang Bio Description and Business Overview
Table 142. Taibang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 143. Taibang Bio Human Coagulation Factor VIII Product
Table 144. Taibang Bio Recent Development
Table 145. Huarun Boya Company Information
Table 146. Huarun Boya Description and Business Overview
Table 147. Huarun Boya Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 148. Huarun Boya Human Coagulation Factor VIII Product
Table 149. Huarun Boya Recent Development
Table 150. Shuanglin Bio Company Information
Table 151. Shuanglin Bio Description and Business Overview
Table 152. Shuanglin Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 153. Shuanglin Bio Human Coagulation Factor VIII Product
Table 154. Shuanglin Bio Recent Development
Table 155. Yuandashuyang Company Information
Table 156. Yuandashuyang Description and Business Overview
Table 157. Yuandashuyang Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 158. Yuandashuyang Human Coagulation Factor VIII Product
Table 159. Yuandashuyang Recent Development
Table 160. Weiguang Bio Company Information
Table 161. Weiguang Bio Description and Business Overview
Table 162. Weiguang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 163. Weiguang Bio Human Coagulation Factor VIII Product
Table 164. Weiguang Bio Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Human Coagulation Factor VIII Distributors List
Table 168. Human Coagulation Factor VIII Customers List
Table 169. Human Coagulation Factor VIII Market Trends
Table 170. Human Coagulation Factor VIII Market Drivers
Table 171. Human Coagulation Factor VIII Market Challenges
Table 172. Human Coagulation Factor VIII Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Human Coagulation Factor VIII Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Factor VIII Product Picture
Figure 5. Plasma-derived Factor VIII Product Picture
Figure 6. Global Human Coagulation Factor VIII Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Human Coagulation Factor VIII Sales Market Share by Application in 2024 & 2031
Figure 8. Hemophilia A Examples
Figure 9. Spontanous / Trauma Examples
Figure 10. Surgical Examples
Figure 11. Other Examples
Figure 12. Global Human Coagulation Factor VIII Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor VIII Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 15. Global Human Coagulation Factor VIII Price Trends Growth Rate (2020-2031) & (USD/Bottle)
Figure 16. Human Coagulation Factor VIII Report Years Considered
Figure 17. Global Market Human Coagulation Factor VIII Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 21. Europe Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 23. China Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 25. Korea Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Korea Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 27. Global Human Coagulation Factor VIII Revenue Share by Type (2020-2025)
Figure 28. Global Human Coagulation Factor VIII Sales Share by Type (2026-2031)
Figure 29. Global Human Coagulation Factor VIII Revenue Share by Type (2026-2031)
Figure 30. Global Human Coagulation Factor VIII Revenue Share by Application (2020-2025)
Figure 31. Global Human Coagulation Factor VIII Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Human Coagulation Factor VIII Sales Share by Application (2026-2031)
Figure 33. Global Human Coagulation Factor VIII Revenue Share by Application (2026-2031)
Figure 34. Global Human Coagulation Factor VIII Sales Share by Company (2024)
Figure 35. Global Human Coagulation Factor VIII Revenue Share by Company (2024)
Figure 36. Global 5 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII: 2020 & 2024
Figure 37. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure 39. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 40. Human Coagulation Factor VIII Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Table 1. Global Human Coagulation Factor VIII Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Human Coagulation Factor VIII Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Human Coagulation Factor VIII Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Coagulation Factor VIII Sales (K Bottles) by Region (2020-2025)
Table 5. Global Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
Table 6. Global Human Coagulation Factor VIII Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Human Coagulation Factor VIII Revenue Share by Region (2020-2025)
Table 8. Global Human Coagulation Factor VIII Sales (K Bottles) Forecast by Region (2026-2031)
Table 9. Global Human Coagulation Factor VIII Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Human Coagulation Factor VIII Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Human Coagulation Factor VIII Revenue Share Forecast by Region (2026-2031)
Table 12. Global Human Coagulation Factor VIII Sales by Type (K Bottles) & (2020-2025)
Table 13. Global Human Coagulation Factor VIII Sales Share by Type (2020-2025)
Table 14. Global Human Coagulation Factor VIII Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Human Coagulation Factor VIII Price by Type (USD/Bottle) & (2020-2025)
Table 16. Global Human Coagulation Factor VIII Sales by Type (K Bottles) & (2026-2031)
Table 17. Global Human Coagulation Factor VIII Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Human Coagulation Factor VIII Price by Type (USD/Bottle) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Human Coagulation Factor VIII Sales by Application (K Bottles) & (2020-2025)
Table 21. Global Human Coagulation Factor VIII Sales Share by Application (2020-2025)
Table 22. Global Human Coagulation Factor VIII Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Human Coagulation Factor VIII Price by Application (USD/Bottle) & (2020-2025)
Table 24. Global Human Coagulation Factor VIII Sales by Application (K Bottles) & (2026-2031)
Table 25. Global Human Coagulation Factor VIII Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Human Coagulation Factor VIII Price by Application (USD/Bottle) & (2026-2031)
Table 27. New Sources of Growth in Human Coagulation Factor VIII Application
Table 28. Global Human Coagulation Factor VIII Sales by Company (K Bottles) & (2020-2025)
Table 29. Global Human Coagulation Factor VIII Sales Share by Company (2020-2025)
Table 30. Global Human Coagulation Factor VIII Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Human Coagulation Factor VIII Revenue Share by Company (2020-2025)
Table 32. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2024)
Table 33. Global Market Human Coagulation Factor VIII Average Price by Company (USD/Bottle) & (2020-2025)
Table 34. Global Key Manufacturers of Human Coagulation Factor VIII, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Human Coagulation Factor VIII, Product Type & Application
Table 36. Global Key Manufacturers of Human Coagulation Factor VIII, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 39. North America Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 40. North America Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 42. North America Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 43. North America Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 44. North America Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 45. North America Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 46. Europe Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 47. Europe Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 48. Europe Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 50. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 51. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 52. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 53. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 54. China Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 55. China Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 56. China Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 58. China Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 59. China Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 60. China Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 61. China Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 62. Korea Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 63. Korea Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 64. Korea Human Coagulation Factor VIII Revenue by Company (2020-2025) & (US$ Million)
Table 65. Korea Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 66. Korea Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 67. Korea Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 68. Korea Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 69. Korea Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 73. Takeda Human Coagulation Factor VIII Product
Table 74. Takeda Recent Development
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 78. Bayer Human Coagulation Factor VIII Product
Table 79. Bayer Recent Development
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 83. CSL Human Coagulation Factor VIII Product
Table 84. CSL Recent Development
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. Pfizer Human Coagulation Factor VIII Product
Table 89. Pfizer Recent Development
Table 90. Grifols Company Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 93. Grifols Human Coagulation Factor VIII Product
Table 94. Grifols Recent Development
Table 95. Biogen Company Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 98. Biogen Human Coagulation Factor VIII Product
Table 99. Biogen Recent Development
Table 100. Octapharma Company Information
Table 101. Octapharma Description and Business Overview
Table 102. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 103. Octapharma Human Coagulation Factor VIII Product
Table 104. Octapharma Recent Development
Table 105. NovoNordisk Company Information
Table 106. NovoNordisk Description and Business Overview
Table 107. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 108. NovoNordisk Human Coagulation Factor VIII Product
Table 109. NovoNordisk Recent Development
Table 110. Greencross Company Information
Table 111. Greencross Description and Business Overview
Table 112. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 113. Greencross Human Coagulation Factor VIII Product
Table 114. Greencross Recent Development
Table 115. Kedrion Company Information
Table 116. Kedrion Description and Business Overview
Table 117. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 118. Kedrion Human Coagulation Factor VIII Product
Table 119. Kedrion Recent Development
Table 120. BPL Company Information
Table 121. BPL Description and Business Overview
Table 122. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 123. BPL Human Coagulation Factor VIII Product
Table 124. BPL Recent Development
Table 125. Hualan Bio Company Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. Hualan Bio Human Coagulation Factor VIII Product
Table 129. Hualan Bio Recent Development
Table 130. RAAS Company Information
Table 131. RAAS Description and Business Overview
Table 132. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 133. RAAS Human Coagulation Factor VIII Product
Table 134. RAAS Recent Development
Table 135. SinoCellTech Company Information
Table 136. SinoCellTech Description and Business Overview
Table 137. SinoCellTech Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 138. SinoCellTech Human Coagulation Factor VIII Product
Table 139. SinoCellTech Recent Development
Table 140. Taibang Bio Company Information
Table 141. Taibang Bio Description and Business Overview
Table 142. Taibang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 143. Taibang Bio Human Coagulation Factor VIII Product
Table 144. Taibang Bio Recent Development
Table 145. Huarun Boya Company Information
Table 146. Huarun Boya Description and Business Overview
Table 147. Huarun Boya Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 148. Huarun Boya Human Coagulation Factor VIII Product
Table 149. Huarun Boya Recent Development
Table 150. Shuanglin Bio Company Information
Table 151. Shuanglin Bio Description and Business Overview
Table 152. Shuanglin Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 153. Shuanglin Bio Human Coagulation Factor VIII Product
Table 154. Shuanglin Bio Recent Development
Table 155. Yuandashuyang Company Information
Table 156. Yuandashuyang Description and Business Overview
Table 157. Yuandashuyang Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 158. Yuandashuyang Human Coagulation Factor VIII Product
Table 159. Yuandashuyang Recent Development
Table 160. Weiguang Bio Company Information
Table 161. Weiguang Bio Description and Business Overview
Table 162. Weiguang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 163. Weiguang Bio Human Coagulation Factor VIII Product
Table 164. Weiguang Bio Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Human Coagulation Factor VIII Distributors List
Table 168. Human Coagulation Factor VIII Customers List
Table 169. Human Coagulation Factor VIII Market Trends
Table 170. Human Coagulation Factor VIII Market Drivers
Table 171. Human Coagulation Factor VIII Market Challenges
Table 172. Human Coagulation Factor VIII Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Human Coagulation Factor VIII Sales Market Share by Type in 2024 & 2031
Figure 4. Recombinant Factor VIII Product Picture
Figure 5. Plasma-derived Factor VIII Product Picture
Figure 6. Global Human Coagulation Factor VIII Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Human Coagulation Factor VIII Sales Market Share by Application in 2024 & 2031
Figure 8. Hemophilia A Examples
Figure 9. Spontanous / Trauma Examples
Figure 10. Surgical Examples
Figure 11. Other Examples
Figure 12. Global Human Coagulation Factor VIII Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor VIII Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 15. Global Human Coagulation Factor VIII Price Trends Growth Rate (2020-2031) & (USD/Bottle)
Figure 16. Human Coagulation Factor VIII Report Years Considered
Figure 17. Global Market Human Coagulation Factor VIII Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 21. Europe Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 23. China Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 25. Korea Human Coagulation Factor VIII Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Korea Human Coagulation Factor VIII Sales (K Bottles) Growth Rate (2020-2031)
Figure 27. Global Human Coagulation Factor VIII Revenue Share by Type (2020-2025)
Figure 28. Global Human Coagulation Factor VIII Sales Share by Type (2026-2031)
Figure 29. Global Human Coagulation Factor VIII Revenue Share by Type (2026-2031)
Figure 30. Global Human Coagulation Factor VIII Revenue Share by Application (2020-2025)
Figure 31. Global Human Coagulation Factor VIII Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Human Coagulation Factor VIII Sales Share by Application (2026-2031)
Figure 33. Global Human Coagulation Factor VIII Revenue Share by Application (2026-2031)
Figure 34. Global Human Coagulation Factor VIII Sales Share by Company (2024)
Figure 35. Global Human Coagulation Factor VIII Revenue Share by Company (2024)
Figure 36. Global 5 Largest Human Coagulation Factor VIII Players Market Share by Revenue in Human Coagulation Factor VIII: 2020 & 2024
Figure 37. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Human Coagulation Factor VIII
Figure 39. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 40. Human Coagulation Factor VIII Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232